TheEdgeResearch
Home / Stocks / NEUP

Neuphoria Therapeutics Inc. (NEUP)

NASDAQ Healthcare Biotechnology
$2.35 ▲ +1.29%
Market Cap
$12.7M
Sector
Healthcare
Industry
Biotechnology
Beta
0.77
52-Wk Range
2.26-5.53
CEO
Spyridon Papapetropoulos
Country
US
Currency
USD

Neuphoria Therapeutics Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Millis, MA, US. The stock last traded at $2.35, up 1.29% on the session, giving a market capitalisation of $12.7M. On trailing twelve-month figures it carries a trailing P/E of -2.75, a net margin of -423.3%. Its beta of 0.77 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.75
Price / Sales
10.83
Price / Book
0.54
EV / EBITDA
0.95
Gross margin
43.5%
Operating margin
-637.8%
Net margin
-423.3%
Return on equity
—
Debt / equity
0.00
Current ratio
18.05
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
1
IPO date
2021-12-16
Headquarters
Millis, MA, US
About Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, develops novel allosteric ion channel modulators for patients with serious central nervous system disorders in Australia. Its lead product candidate is BNC210, an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor for post-traumatic stress disorder. The company also develops Merck alpha7 positive allosteric modulators. It has a research collaboration and license agreement with Merck & Co., Inc. to develop alpha7 receptor positive allosteric modulators targeting cognitive dysfunction associated with Alzheimer's disease and other central nervous system conditions. The company was formerly known as Bionomics Limited and changed its name to Neuphoria Therapeutics Inc. in December 2024. Neuphoria Therapeutics Inc. was incorporated in 1996 and is based in Millis, Massachusetts.

Comparable companies

Neuphoria Therapeutics Inc. is most often compared with the following Healthcare names:

ALZNAPREBCDABMRACHEKIINNLFWDLUCYPFSAPTHL
More research on NEUP
NEUP technical analysis NEUP TheEdge Score Compare against peers
Open full interactive analysis & DCF →